Table 3.
Results of consistency analysis by node‐splitting plot
| Study | P value | Odds ratio (95% CI/CrI) |
|---|---|---|
| ACEIs vs placebo | ||
| Direct | .072 | 0.73 (0.55–0.91) |
| Indirect | 1.10 (0.76–1.50) | |
| Network | 0.82 (0.66–0.99) | |
| ARBs vs placebo | ||
| Direct | .809 | 0.78 (0.60–0.97) |
| Indirect | 0.73 (0.46–1.10) | |
| Network | 0.77 (0.63–0.92) | |
| β‐Blockers vs placebo | ||
| Direct | .108 | 2.20 (1.10–4.40) |
| Indirect | 1.10 (0.83–1.50) | |
| Network | 1.20 (0.92–1.60) | |
| CCBs vs placebo | ||
| Direct | .568 | 1.20 (0.72–1.90) |
| Indirect | 1.00 (0.74–1.30) | |
| Network | 1.00 (0.82–1.30) | |
| Diuretics vs placebo | ||
| Direct | .361 | 1.60 (1.00–2.50) |
| Indirect | 1.30 (0.94–1.80) | |
| Network | 1.40 (1.10–1.80) | |
| β‐Blockers vs ACEIs | ||
| Direct | .575 | 1.30 (0.78–2.20) |
| Indirect | 1.60 (1.10–2.30) | |
| Network | 1.50 (1.10–2.00) | |
| β‐Blockers+diuretics vs ACEIs | ||
| Direct | .535 | 1.10 (0.58–2.10) |
| Indirect | 1.50 (0.73–3.10) | |
| Network | 1.30 (0.82–2.10) | |
| CCBs vs ACEIs | ||
| Direct | .970 | 1.30 (0.81–1.90) |
| Indirect | 1.30 (0.89–1.90) | |
| Network | 1.30 (0.99–1.70) | |
| Diuretics vs ACEIs | ||
| Direct | .127 | 1.40 (0.92–2.00) |
| Indirect | 2.00 (1.50–2.90) | |
| Network | 1.70 (1.30–2.20) | |
| β‐Blockers vs ARBs | ||
| Direct | .948 | 1.60 (0.96–2.60) |
| Indirect | 1.60 (1.10–2.30) | |
| Network | 1.60 (1.20–2.10) | |
| CCBs vs ARBs | ||
| Direct | .846 | 1.40 (0.84–2.30) |
| Indirect | 1.30 (0.99–1.90) | |
| Network | 1.40 (1.00–1.80) | |
| Diuretics vs ARBs | ||
| Direct | .722 | 2.00 (1.00–4.10) |
| Indirect | 1.80 (1.30–2.50) | |
| Network | 1.8 (1.40–2.40) | |
| CCBs vs β‐blockers | ||
| Direct | .796 | 0.83 (0.54–1.20) |
| Indirect | 0.90 (0.59–1.30) | |
| Network | 0.86 (0.65–1.10) | |
| Diuretics vs β‐blockers | ||
| Direct | .624 | 1.20 (0.87–1.70) |
| Indirect | 1.10 (0.72–1.60) | |
| Network | 1.10 (0.88–1.50) | |
| CCBs vs β‐blockers+diuretics | ||
| Direct | .584 | 0.89 (0.48–1.70) |
| Indirect | 1.10 (0.58–2.20) | |
| Network | 0.99 (0.63–1.60) | |
| Diuretics vs CCBs | ||
| Direct | .911 | 1.30 (0.80–2.10) |
| Indirect | 1.30 (0.93–1.90) | |
| Network | 1.30 (1.00–1.70) | |
Abbreviations: ACEIs, angiotensin‐converting enzyme inhibitors; ARBs, angiotensin II receptor blockers; CCBs, calcium channel blockers; CI, confidence interval; CrI, credible interval.